Antiandrogens Market is projected to register a CAGR of 7.1% during the forecast period due to the increased demand for functional products
Research Reports
Oct 11, 2023
Antiandrogens Market Research Report: Information By Type (Steroidal and Nonsteroidal), By Disease Indication (Prostate Cancer, Benign Prostatic Hyperplasia, Hirsutism, Hyperandrogenism, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Online Pharmacies) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032
The Antiandrogens market industry is projected to grow from USD 5.4 Billion in 2023 to USD 9.5 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 7.1% during the forecast period (2023 – 2032).
Antiandrogens are a broad category of medications that antagonize the effects of testosterone, dihydrotestosterone, and the male sex hormones. They are sometimes called androgen antagonists, receptor inhibitors, and testosterone blockers. Several antiandrogens restrict the body’s utilization of androgens by inhibiting androgen receptors. Acne, hirsutism, seborrhea, and hyperandrogenism are all conditions that antiandrogens are used to treat in women and girls. Common male pattern baldness, more than 95 percent of men in the United States experience hair loss yearly. Anti-androgens bind to androgen receptors and stop androgens from causing tumor growth. Alopecia results in hair loss or baldness. The illness does not just affect the head and can cause hair loss on any part of the body. Hair loss can be temporary or permanent, depending on the type of alopecia. In the large group of hormones known as androgens, testosterone is a dominating sex hormone in men.
Get Free Sample PDF Brochure @
https://www.marketresearchfuture.com/sample_request/12199
Between 4% and 7% of women have ovaries that produce too much testosterone. Polycystic ovarian syndrome is a disorder that affects antiandrogen-using women. The condition on a woman’s body may result in overgrowth of hair in places like the chin and over the lips. It can also result in amenorrhea and acne. A common skin problem is acne. It is brought on by inflammation of the skin’s sebaceous (oil-producing) glands and hair follicles. This condition is known as amenorrhea when a woman of childbearing age does not have a period. The prevalence of male pattern hair loss, precocious puberty in young men, benign prostatic hyperplasia, and hypersexuality is expected to rise during the projection period, driving demand for antiandrogens. For metastatic prostate cancer, an alternative to androgen deprivation treatment with surgery or pharmaceutical castration is antiandrogen monotherapy. Castration, whether surgical or drug-induced, is linked to impotence and a lack of desire and thus might not always be satisfactory to the patient. The market for antiandrogen monotherapy is also anticipated to develop throughout the forecast period as prostate cancer incidence rates rise.
Market Segmentation
The market for antiandrogens is divided into steroidal and nonsteroidal products based on kind. Hospitals, retail stores, and internet pharmacies are included in the market segmentation for antiandrogens based on distribution channels. Prostate cancer, hirsutism, hyperandrogenism, benign prostatic hyperplasia, and other diseases are included in the market segmentation for antiandrogens based on disease indication.
Market Competitive Landscape:
- Bristol-Myers Squibb Company
- Progenics Pharmaceuticals, Inc.,
- Novartis AG
- ALZA Corporation
- Pfizer Inc.
- Astellas Pharma Inc.
- Hoffmann-La Roche Ltd.
- OSI Pharmaceuticals, Inc.
- Genentech Inc.
- Sanofi SA
- AstraZeneca Plc
- Abbott Laboratories
- Amgen Inc
- Takeda Pharmaceutical Company Limited
- GlaxoSmithKline Plc
Regional Insights
The North American anti-androgen market will dominate this market. Antiandrogens are often used to treat prostate cancer, a severe issue in North America. Recent developments in cancer treatment, such as targeted drugs and combination therapy, may have impacted the market’s growth. The market for antiandrogens is second only to that of Asia. Antiandrogens are a crucial component of prostate cancer treatment, and as Europe’s population ages, so does its susceptibility to conditions like prostate cancer. Prostate cancer is becoming more commonplace throughout the continent, driving the consumption of antiandrogens and stimulating market expansion.
Browse In-depth Market Research Report (128 Pages) on Antiandrogens:
https://www.marketresearchfuture.com/reports/antiandrogens-market-12199
Discover More Research Reports on Healthcare Industry by Market Research Future:
Companion Diagnostics Market Research Report Information by Product & Service (Assays, Kits, & Reagents and Software & Services), by Technology (Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), In Situ Hybridization (ISH), Immunohistochemistry (IHC), and Others), by Indication (Cancer [Lung Cancer, Breast Cancer, Colorectal Cancer, Gastric Cancer, Melanoma, and Others], Neurological Diseases, Infectious Diseases, Cardiovascular Diseases, and Others), by End User (Pharmaceutical & Biopharmaceutical Companies, Contract Research.
Diabetes Monitors Market Research Report By Sample (Blood, Sweat, Urine), Type (Point Sample Test-Based Glucose Monitors, CGM, Component (Lancet, Glucose Test Strips, Sensors (Enzyme Based and Enzyme Free Sensors)), End Users – Forecast till 2032
Wearable Injectors Market Research Report Information By Type (On-Body, Off-Body, Hand Held), Usage (Disposable, Semi-Reusable), Mechanism of Injection (Spring Based), Therapeutic Area (Oncology, Diabetes), End-User- Forecast Till 2030
Respiratory Care Devices Market: Therapeutic devices (PAP Devices), Monitoring devices (Pulse Oximeters), Diagnostic devices (Spirometers), Accessories & Consumables (Disposable Masks), and Application (Asthma and Others)- Forecast till 2030
Blood Screening Market: By Technology (Nucleic Acid Amplification Test, Enzyme-Linked Immunosorbent Assay, Next-Generation Sequencing), Product and Services (Reagents, Instruments) and End User (Hospitals and Clinics) – Forecast till 2030
About Market Research Future:
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.
Follow Us: LinkedIn | Twitter
Contact Information:
Contact: Market Research Future (Part of Wantstats Research and Media Private Limited) 99 Hudson Street, 5Th Floor New York, NY 10013 United States of America +1 628 258 0071 (US) +44 2035 002 764 (UK) Email: sales@marketresearchfuture.com Website: https://www.marketresearchfuture.com
Tags:
Research Newswire, English